{
 "companyname": "IMMUNOCELLULAR THERAPEUTICS, LTD.",
 "symbol": "IMUC",
 "description": "Pharmaceutical Preparations",
 "quarters": [
  {
   "cik": "0000822411",
   "companyname": "IMMUNOCELLULAR THERAPEUTICS, LTD.",
   "entityid": 69466,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "IMUC",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "11/9/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001564590-15-010219",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": null,
   "changeincurrentliabilities": 1183366,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -163307,
   "cashfromfinancingactivities": 6750,
   "cashfrominvestingactivities": -163307,
   "cashfromoperatingactivities": -6316244,
   "cfdepreciationamortization": 6997,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": -6472801,
   "totaladjustments": -2914989,
   "ebit": -3745889,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 0,
   "incomebeforetaxes": -3401255,
   "interestexpense": 0,
   "netincome": -3401255,
   "netincomeapplicabletocommon": -3401255,
   "researchdevelopmentexpense": 2592255,
   "totalrevenue": 0,
   "sellinggeneraladministrativeexpenses": 1153634,
   "commonstock": 9031,
   "deferredcharges": 0,
   "cashandcashequivalents": 24435152,
   "cashcashequivalentsandshortterminvestments": 24435152,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 4889501,
   "othercurrentassets": 1328955,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": 2555735,
   "preferredstock": null,
   "propertyplantequipmentnet": 196833,
   "retainedearnings": -69327757,
   "totalassets": 30850441,
   "totalcurrentassets": 25764107,
   "totalcurrentliabilities": 2004932,
   "totalliabilities": 4560667,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 26289774,
   "treasurystock": null
  },
  {
   "cik": "0000822411",
   "companyname": "IMMUNOCELLULAR THERAPEUTICS, LTD.",
   "entityid": 69466,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "IMUC",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/7/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001564590-15-006689",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": null,
   "changeincurrentliabilities": -664847,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -4685,
   "cashfromfinancingactivities": 0,
   "cashfrominvestingactivities": -4685,
   "cashfromoperatingactivities": -3858541,
   "cfdepreciationamortization": 6592,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": -3863226,
   "totaladjustments": -703811,
   "ebit": -3387589,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 0,
   "incomebeforetaxes": -3154730,
   "interestexpense": 0,
   "netincome": -3154730,
   "netincomeapplicabletocommon": -3154730,
   "researchdevelopmentexpense": 2236817,
   "totalrevenue": 0,
   "sellinggeneraladministrativeexpenses": 1150772,
   "commonstock": 9025,
   "deferredcharges": 0,
   "cashandcashequivalents": 30907953,
   "cashcashequivalentsandshortterminvestments": 30907953,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 904102,
   "othercurrentassets": 1302579,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": 2894871,
   "preferredstock": null,
   "propertyplantequipmentnet": 40523,
   "retainedearnings": -65926502,
   "totalassets": 33155157,
   "totalcurrentassets": 32210532,
   "totalcurrentliabilities": 821566,
   "totalliabilities": 3716437,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 29438720,
   "treasurystock": null
  },
  {
   "cik": "0000822411",
   "companyname": "IMMUNOCELLULAR THERAPEUTICS, LTD.",
   "entityid": 69466,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "IMUC",
   "siccode": "2834",
   "sicdescription": "Pharmaceutical Preparations",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/11/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001564590-15-003958",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": null,
   "changeincurrentliabilities": 197214,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -1758,
   "cashfromfinancingactivities": 14599627,
   "cashfrominvestingactivities": -1758,
   "cashfromoperatingactivities": -3048986,
   "cfdepreciationamortization": 6693,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": 11548883,
   "totaladjustments": -1624140,
   "ebit": -3101120,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 0,
   "incomebeforetaxes": -1424846,
   "interestexpense": -88939,
   "netincome": -1424846,
   "netincomeapplicabletocommon": -1424846,
   "researchdevelopmentexpense": 1998619,
   "totalrevenue": 0,
   "sellinggeneraladministrativeexpenses": 1102501,
   "commonstock": 9025,
   "deferredcharges": 0,
   "cashandcashequivalents": 34771179,
   "cashcashequivalentsandshortterminvestments": 34771179,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 553805,
   "othercurrentassets": 1610391,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": 3122077,
   "preferredstock": null,
   "propertyplantequipmentnet": 42430,
   "retainedearnings": -62771772,
   "totalassets": 36977805,
   "totalcurrentassets": 36381570,
   "totalcurrentliabilities": 1486413,
   "totalliabilities": 4608490,
   "totallongtermdebt": null,
   "totalreceivablesnet": null,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 32369315,
   "treasurystock": null
  }
 ]
}